Patent details

EP2841084 Title: CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2841084
WO Application Number:
IL2013050352
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP13727657.2
WO Publication Number:
WO2013160895
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Israel (IL)
Publications:

Dates

Filing date:
24/04/2013
Grant date:
30/05/2018
EP Publication Date:
04/03/2015
WO Publication Date:
31/10/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
21/08/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
30/05/2018
EP B1 Publication Date:
30/05/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
23/04/2033
Lapsed By Expiration Date:
Patent Validated Date:
31/08/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
30/05/2018
 
 

 

Name:
Biokine Therapeutics Ltd.
Address:
Building 13a Einstein Street, Science Park Kiryat Weizmann, 70400 NES ZIONA, Israel (IL)

Agent

Name:
ir. W.J.J.M. Kempes
From:
30/08/2018
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

1

Name:
PELED, Amnon
Address:
67776 Tel-Aviv, Israel (IL)

2

Name:
WALD, Ori
Address:
64516 Tel-Aviv, Israel (IL)

Priority

Priority Patent Number:
201261637334 P
Priority Date:
24/04/2012
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/282; A61K 31/337; A61K 38/10; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
37/18
Publication date:
05/09/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
23/18
Publication date:
30/05/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201822
Publication date:
30/05/2018
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/04/2026
Annual Fee Number:
14
Annual Fee Amount:
800 Euro
Last Annual Payment Date:
18/04/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
700 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
30/08/2018 Outgoing Correspondence Letter no formal defects 1 PDF /1/7/4/5/7/0800275471/docs/ep13727657.2_0_225717l271.pdf
21/08/2018 Claims First filed claims 1 PDF /1/7/4/5/7/0800275471/docs/ep13727657.2_1_claims20180821150832357.pdf
21/08/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /1/7/4/5/7/0800275471/docs/ep13727657.2_2_incomingcorrespondenceelectronic20180821150832631.pdf